文章
![](https://clbiomed.com/wp-content/uploads/2020/08/2016年10月30日-马蔚华拜访沃森-495x400.jpg)
![](https://clbiomed.com/wp-content/uploads/2020/08/1596157065357723-495x400.jpeg)
乐土投资的全新靶向抗体药公司Immune-Onc开展新一轮融资加快研发临床管线
乐土海外投资项目之一,其领先在研产品创新癌症免疫疗法IO-202的临床试验申请(IND)于今年5月获得美国FDA批准,目前刚刚开启新一轮融资。
Portfolio Items
![](https://clbiomed.com/wp-content/uploads/2020/07/Leaf-product-1-495x400.jpg)
Leaf Healthcare
智能医疗器械公司
![](https://clbiomed.com/wp-content/uploads/2020/07/Sentieon-feature-495x400.jpg)
![](https://clbiomed.com/wp-content/uploads/2020/07/Centrillion-feature-495x400.jpg)
Centrillion
第三代基因检测芯片
![](https://clbiomed.com/wp-content/uploads/2020/07/twoXAR-feature-495x400.jpg)
![](https://clbiomed.com/wp-content/uploads/2020/07/Neocis-feature-495x331.jpg)
![](https://clbiomed.com/wp-content/uploads/2020/07/Guardant-feature-495x400.jpg)
Guardant Health
癌症液体活检和伴随诊断
![](https://clbiomed.com/wp-content/uploads/2020/07/Synlogic-feature-495x400.jpg)
Synlogic Therapeutics
生物工程微生物药物
![](https://clbiomed.com/wp-content/uploads/2020/07/TurningPoint-feature-495x400.jpg)
Turning Point Therapeutics
癌症和其他疾病精准治疗
![](https://clbiomed.com/wp-content/uploads/2020/07/ImmuneOnc-feature-495x400.jpg)
Immune–Onc Therapeutics
癌症免疫药物研发项目
![](https://clbiomed.com/wp-content/uploads/2020/07/Compass-feature-495x400.jpg)
Compass Therapeutics
免疫治疗的一线新药上市公司
![](https://clbiomed.com/wp-content/uploads/2020/07/CRSPR-495x400.jpg)
CRISPR Therapeutics
基因编辑医疗领域领先的上市公司